US Stock MarketDetailed Quotes
PTIXW PROTAGENIC THERAPEUTICS INC C/WTS 13/04/2025 (TO PUR COM)
- 0.0225
- 0.00000.00%
Close Apr 26 16:00 ET
0Market Cap0.00P/E (TTM)
0.0000High0.0000Low0Volume0.0225Open0.0225Pre Close0.00Turnover0.00%Turnover Ratio0.00P/E (Static)0Shares0.040052wk High0.00P/B0Float Cap0.002452wk Low--Dividend TTM0Shs Float0.7999Historical High--Div YieldTTM0.00%Amplitude0.0024Historical Low--Avg Price1Lot Size
PROTAGENIC THERAPEUTICS INC C/WTS 13/04/2025 (TO PUR COM) Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | (Q1)Mar 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Cash, cash equivalents and short term investments | -49.16%4.06M | -49.16%4.06M | -35.33%5.27M | -31.86%6.04M | -21.82%7.65M | -23.07%7.98M | -23.07%7.98M | -24.89%8.15M | -25.68%8.87M | 5,005.22%9.79M |
| -Cash and cash equivalents | 498.49%1.29M | 498.49%1.29M | -3.15%153.33K | -35.21%219.44K | -71.28%138.49K | -60.24%215.19K | -60.24%215.19K | -65.59%158.32K | -97.16%338.67K | 151.56%482.18K |
| -Short-term investments | -64.34%2.77M | -64.34%2.77M | -35.96%5.12M | -31.73%5.82M | -19.25%7.51M | -21.02%7.76M | -21.02%7.76M | -23.09%7.99M | --8.53M | --9.3M |
| Prepaid assets | 152.95%144.03K | 152.95%144.03K | 2.45%104.08K | 498.16%874.67K | 8.53%14.02K | -91.73%56.94K | -91.73%56.94K | -87.34%101.58K | 13.21%146.23K | 189.10%12.92K |
| Total current assets | -47.73%4.2M | -47.73%4.2M | -34.86%5.38M | -23.26%6.92M | -21.78%7.66M | -27.34%8.04M | -27.34%8.04M | -29.19%8.25M | -25.27%9.01M | 4,895.51%9.8M |
| Non current assets | ||||||||||
| Net PPE | 6,848.28%123.33K | 6,848.28%123.33K | --55.98K | --1.6K | --1.69K | --1.78K | --1.78K | ---- | ---- | ---- |
| Total non current assets | 6,848.28%123.33K | 6,848.28%123.33K | --55.98K | --1.6K | --1.69K | --1.78K | --1.78K | --0 | --0 | --0 |
| Total assets | -46.21%4.32M | -46.21%4.32M | -34.18%5.43M | -23.24%6.92M | -21.76%7.67M | -27.33%8.04M | -27.33%8.04M | -29.19%8.25M | -25.27%9.01M | 4,895.51%9.8M |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Payables | ---- | ---- | 74.77%243.52K | -52.69%158.17K | -37.39%174.87K | ---- | ---- | -49.08%139.34K | 80.97%334.3K | 19.49%279.29K |
| -accounts payable | ---- | ---- | 74.77%243.52K | -52.69%158.17K | -37.39%174.87K | ---- | ---- | -49.08%139.34K | 80.97%334.3K | 19.49%279.29K |
| Current accrued expenses | ---- | ---- | 48.94%616.82K | 639.89%952.91K | 40.37%707.97K | ---- | ---- | -8.13%414.14K | -69.18%128.79K | 20.88%504.35K |
| Current debt and capital lease obligation | ---- | ---- | --419.76K | --394.31K | --369.13K | --344.23K | --344.23K | ---- | ---- | ---- |
| -Current debt | ---- | ---- | --419.76K | --394.31K | --369.13K | --344.23K | --344.23K | ---- | ---- | ---- |
| Current liabilities | -41.49%655.25K | -41.49%655.25K | 131.28%1.28M | 225.08%1.51M | 59.76%1.25M | 40.06%1.12M | 40.06%1.12M | -23.60%553.48K | -23.15%463.09K | 20.38%783.64K |
| Non current liabilities | ||||||||||
| Long term debt and capital lease obligation | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -43.29%318.78K | -55.65%293.32K | -80.69%295.06K |
| -Long term debt | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -43.29%318.78K | -55.65%293.32K | -80.69%295.06K |
| Total non current liabilities | --0 | --0 | --0 | --0 | --0 | --0 | --0 | -43.29%318.78K | -55.65%293.32K | -80.69%295.06K |
| Total liabilities | -41.49%655.25K | -41.49%655.25K | 46.76%1.28M | 99.02%1.51M | 16.06%1.25M | 0.17%1.12M | 0.17%1.12M | -32.20%872.26K | -40.16%756.41K | -50.49%1.08M |
| Shareholders'equity | ||||||||||
| Share capital | 2.30%444 | 2.30%444 | -74.90%434 | -74.90%434 | -74.86%434 | 0.46%434 | 0.46%434 | 1.89%1.73K | 6.20%1.73K | 62.52%1.73K |
| -common stock | 2.30%444 | 2.30%444 | -74.90%434 | -74.90%434 | -74.86%434 | 0.46%434 | 0.46%434 | 1.89%1.73K | 6.27%1.73K | 62.68%1.73K |
| -Preferred stock | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Retained earnings | -19.40%-30.78M | -19.40%-30.78M | -15.59%-29.1M | -14.24%-27.71M | -12.35%-26.5M | -16.00%-25.78M | -16.00%-25.78M | -18.02%-25.18M | -18.57%-24.25M | -24.75%-23.58M |
| Paid-in capital | 3.56%34.56M | 3.56%34.56M | 2.11%33.87M | 2.27%33.7M | 2.56%33.54M | 2.96%33.37M | 2.96%33.37M | 4.07%33.17M | 4.89%32.96M | 91.32%32.7M |
| Gains losses not affecting retained earnings | 83.23%-113.55K | 83.23%-113.55K | -0.43%-617.74K | -30.42%-586.46K | -57.44%-628.76K | -172.56%-676.91K | -172.56%-676.91K | -256.84%-615.11K | -163.57%-449.68K | -133.41%-399.36K |
| Total stockholders'equity | -46.97%3.67M | -46.97%3.67M | -43.75%4.15M | -34.44%5.41M | -26.44%6.41M | -30.42%6.92M | -30.42%6.92M | -28.82%7.38M | -23.52%8.26M | 539.81%8.72M |
| Total equity | -46.97%3.67M | -46.97%3.67M | -43.75%4.15M | -34.44%5.41M | -26.44%6.41M | -30.42%6.92M | -30.42%6.92M | -28.82%7.38M | -23.52%8.26M | 539.81%8.72M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg